The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Clinical trial coordinators need more financial conflict-of-interest training

DURHAM, N.C. -- Medical professionals conducting clinical trials should provide more information about financial conflicts of interest before they talk to patients about participating in the trials.

That is one of the main conclusions of a new survey by researchers from Duke University Medical Center and Johns Hopkins University. Their study found that 41 percent of the clinical trial coordinators surveyed had experience disclosing financial aspects of the trial to potential participants, and 28 percent of the coordinators had been asked by participants about potential financial conflicts.

Financial interests can include such things as corporate support for the costs of the trial and its personnel, a researcher's consulting contract with a company that has a vested interest in a trial and an investigator's ownership of stock in a sponsoring company. Clinical trial coordinators usually conduct most of the informed consent process by explaining to potential participants such details of the study as possible health benefits and risks. But more frequently now, the talk also includes financial conflicts of interest when they are relevant to the particular trial.

"We found that coordinators who had more experience discussing financial matters felt more comfortable in discussing them with potential clinical trial participants," said Joelle Friedman, who presented the results of the latest survey April 22, 2007, during the annual meeting of the Association of Clinical Research Professionals in Seattle. Jeremy Sugarman, M.D., of Johns Hopkins Berman Institute of Bioethics, also participated in the presentation.

"When we asked the coordinators what they felt were the major barriers to providing financial information to patients, 76 percent cited lack of information about the financial aspects of the trial and 26 percent said they didn't think the patient would understand the disclosure," Friedman continued.

The survey was p
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
22-Apr-2007


Page: 1 2 3

Related medicine news :

1. Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer
2. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
3. Clinical review -- A psychological approach to the management of irritable bowel syndrome
4. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
5. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
6. Clinical guidelines for blood conservation during cardiac procedures developed
7. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
8. Clinical studies evaluate potential treatments for mouth ulcers
9. NIH names Clinical Trial Units for the Microbicide Trials Network
10. Clinical Trials Units selected for newly restructured HIV/AIDS research networks
11. Study in recent issue of Clinical Pediatrics helps pediatricians to understand discipline practices

Post Your Comments:
(Date:11/23/2009)... After suffering from women,s hair loss for almost... and she,s sharing her progress and the secret beh...ugh the release of her video diaries which include... her treatment. , (PRWeb ...ferer Zsanett Siklosi has released the video diari...
(Date:11/23/2009)...TargetIndividualsintheRecommendedPriorityGroups ,...--TheDepartmentofHealthannouncedtodaytheywillcondu...eHealthCentersinDelaware,Lancaster,andLehighcounti...inewillbeadministeredforfreetoindividualsinthereco...hevaccine.Thedepartmentasksthatonlyindividualsinth...
(Date:11/23/2009)...care professionals enjoy a pay raise for a job wel...s for health care performance may actually backfir... performance ratings for 25 medical groups across ...unch of a statewide pay-for-performance program in... productivity. , Reporting in the December ed...
(Date:11/23/2009)...t woman to head the agency, said lives could be at...s) -- The fallout from last week,s controversial r...e mammogram testing for breast cancer continues, w...of Health advising women to ignore the guidelines....ause unequivocally this will increase the number o...
(Date:11/23/2009)...caretofinance"reform"isamoraloutrage ,, WASHI...eDemocratsmovedforwardtobeginthedebateontheirhealt...pporterstronggrassrootssenioradvocacygroup,iscalli...testthemassivecutstoMedicare.RetireSafePresidentTh...issuesliketaxes,abortion,andimmigration,whilethesi...
Breaking Medicine News(10 mins):Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3Health News:RetireSafe Calls on Seniors to Grab their Bullhorns to Save Medicare from Rationed Care 2
(Date:11/23/2009)...PRNewswire/--BioTrendsResearchGroup,Inc.releasedWa...esecondinamulti-phasesyndicatedmarketresearchproje...me,throughthefirstsixmonthsofproductavailability.E...rom50uniqueNephrologistsandqualitativeinformationf...me,obstaclestouse,reasonstouse,typicalpatienttypes...
(Date:11/23/2009)...23/PRNewswire/--AMDLASERSannouncedthisweekthatitco...artneringwithprestigiousindustry-leaderDr.LarryRos...llbetheexclusivesofttissuediodelaserusedduringalli...tothetop2%ofdentists. ,, (Photo: http://www.new...iswithgreatpleasurethatIproudlyannounceourpartners...
(Date:11/23/2009)....23/PRNewswire-FirstCall/--RaptorPharmaceuticalCor...uncedthepresentationofclinicaltrialdataonNGX426,th...tereceptorantagonist,atthe12thInternationalConfere...ldonNovember20-21inSanFrancisco.Theresultsofthestu...siologyattheCenterforPainMedicineoftheUniversityof...
Breaking Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5Surgery Better Than Angioplasty for Narrowed Neck Artery 55646 1Surgery Better Than Angioplasty for Narrowed Neck Artery 55646 2Surgery Better Than Angioplasty for Narrowed Neck Artery 55646 3Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 1Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 2Diet to Go Asks 3A Isn 26apos 3Bt it TIME You Listened to the Facts About Weight Loss 3F 55642 3Dementia More Likely With One Subtype of HIV 55639 1
Other News:
...ople with advanced gastrointestinal stromal tumors...periods continue to benefit from the drug, accordi... University Cancer Institute researchers. ...... ... of the OHSU Cancer Institute Solid Tumors Program...
Many patients who have broken a major bone are not getting adequate advice or health care from their medical practitioners, according to new research presented this week at the IOF World Congress on O
...vanced prostate cancer can be treated successfully...udy conducted by Oregon Health & Science Universit...portant because the optimal duration of chemothera...wn. In many studies of newer chemotherapy drugs, p...
... - Researchers at the University of Pennsylvania S...of female heart failure patients who underwent a s... -- concluded that women tend to have lower maximu... is significantly better than men. The results sug...
health news:Five-year study confirms Gleevec's long-term benefits 2health news:Diagnosis and treatment of osteoporosis falls shortnon adherence compounds issue 2health news:Diagnosis and treatment of osteoporosis falls shortnon adherence compounds issue 3health news:Diagnosis and treatment of osteoporosis falls shortnon adherence compounds issue 4health news:Diagnosis and treatment of osteoporosis falls shortnon adherence compounds issue 5health news:Diagnosis and treatment of osteoporosis falls shortnon adherence compounds issue 6health news:Advanced prostate cancer remains sensitive to treatment even after holidays from chemotherapy 2health news:Penn researchers question change in 'gold standard' for assessing heart failure treatment 2health news:Penn researchers question change in 'gold standard' for assessing heart failure treatment 3
...(May 20, 2002) - The FDA has approved a new ...35 ...onate sodium tablets) for the prevention and treat...l offers patients the convenience of a once-a-week...otect their bones. It will be available in mid-Ju...
... women in the United States...have an abnormal Pap...n or treatment. This weeks issue of the Journal of...new national consensus guidelines designed to help......evaluate women whose Pap tests suggest they may...
Seville, Spain, May 21, 2002 The first recombinant Factor VIII therapy for Haemophilia A prepared entirely without the use of human- or animal-derived additives was found to be bioequivalent to the cu
... Pharmaceuticals, a division of Wyeth (NYSE:WYE), ...epression maintained remission of their symptoms, ... their disease, after a year of therapy with the a...ing to data from a multicenter trial presented at ...
health news:New guidelines for managing women with abnormal pap smears 2health news:First clinical data presented on latest technological advance in haemophilia a therapy 2health news:Effexor (R) XR achieved long-term remission in 67 percent of recurring depression patients 2health news:Effexor (R) XR achieved long-term remission in 67 percent of recurring depression patients 3